医学
回顾性队列研究
儿科
脑病
疾病严重程度
疾病
神经系统疾病
多中心研究
中枢神经系统疾病
年轻人
内科学
重症监护医学
厄尔尼诺现象
热性惊厥
神经影像学
作者
Sevgi Kuş,Şilem Özdem Alataş,Gülşen Akkoç,Sevliya Öcal Demir,Mustafa Gençeli,Murat Sütçü,Sema Yıldırım Arslan,Esra Çiftci,Selim Öncel,Gül Arga,Şefika Elmas Bozdemir,Elif Kıymet,Yıldız Ekemen Keleş,Edanur Yeşil,Manolya Kara,Nazan Dalgıç,Ümit Çelik,Canan Özlü,Ayşe Tekin Yılmaz,Esra Çakmak Taşkın
标识
DOI:10.1007/s00431-026-07411-6
摘要
Abstract Background Influenza-associated neurological complications (IANC) encompass a broad spectrum ranging from febrile seizures to severe encephalopathy with substantial morbidity and mortality. We aimed to describe the clinical characteristics and outcomes of pediatric IANC and evaluate the prognostic utility of the Neuroinfluenza Severity Score (NISS). Methods This retrospective multicenter study included children aged 1 month to 18 years hospitalized with laboratory-confirmed influenza and neurological manifestations at 21 tertiary centers in Türkiye during the 2023–2025 influenza seasons. Clinical, laboratory, neuroimaging, treatment, and six-month follow-up data were analyzed. NISS was developed using variables reflecting disease severity, and outcome analysis was performed. Results Among 5,093 hospitalized children with influenza, 397 (7.8%) developed neurological complications. The median age was 45.6 months, and 70.8% were younger than five years. Seizures were the most frequent manifestation (70.8%), followed by encephalopathy (10.9%) and meningoencephalitis (5.0%). Complete neurological recovery occurred in 90.2% of patients, whereas 5.0% developed long-term neurological sequelae, and overall mortality was 1.3%. ROC analysis demonstrated excellent predictive performance of NISS for unfavorable neurological outcomes, with an optimal cutoff ≥ 2 yielding 82.1% sensitivity and 91.9% specificity (AUC 0.913, 95% CI 0.856–0.969; p < 0.001). Patients with severe neuroinfluenza were associated with delayed oseltamivir initiation, prolonged hospitalization, elevated inflammatory markers, and more frequent high-risk neuroimaging abnormalities and had significantly long-term neurological sequelae (29.5% vs. 0.6%), and mortality (8.2% vs. 0%). Conclusions IANC should be considered in children presenting with acute neurological manifestations, even in the absence of respiratory symptoms. The NISS demonstrated excellent ability to identify patients at increased risk of poor neurological outcomes, long-term sequelae, and mortality, providing a practical tool for early risk stratification and timely escalation of care.
科研通智能强力驱动
Strongly Powered by AbleSci AI